Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Neuroblastoma"" wg kryterium: Temat


Tytuł:
GSTO2 ameliorates human neuroblastoma cell apoptosis, inflammation, ferroptosis, and oxidative stress by upregulating GPX4 expression in intracerebral hemorrhage.
Autorzy:
Liu C; Department of Neurosurgery, Hanyang Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, China.
Tian W; Department of Neurosurgery, Hanyang Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, China.
Lei D; Department of Neurosurgery, Hanyang Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, China.
Pokaż więcej
Źródło:
Drug development research [Drug Dev Res] 2024 Sep; Vol. 85 (6), pp. e22245.
Typ publikacji:
Journal Article
MeSH Terms:
Ferroptosis*/drug effects
Ferroptosis*/physiology
Oxidative Stress*/drug effects
Phospholipid Hydroperoxide Glutathione Peroxidase*/metabolism
Cerebral Hemorrhage*/metabolism
Apoptosis*/drug effects
Up-Regulation*
Inflammation*/metabolism
Neuroblastoma*/metabolism
Neuroblastoma*/pathology
Humans ; Cell Line, Tumor ; Glutathione Transferase/metabolism ; Cell Proliferation/drug effects ; Hemin/pharmacology ; Reactive Oxygen Species/metabolism
Czasopismo naukowe
Tytuł:
Establishment and characterization of a novel MDM2/MYCN-co-amplified neuroblastoma cell line, NBN-SHIM, established from a late recurrent stage MS tumor.
Autorzy:
Kato K; Divisions of Pathology, Kanagawa Children's Medical Center, Yokohama, Japan. .; Division of Pediatric Hematology and Oncology, Institute of Pediatric Medicine and Cancer Research, Ibaraki Children's Hospital, Futaba-dai 3-3-1, Mito, Ibaraki, Japan. .
Nagai JI; Divisions of Pathology, Kanagawa Children's Medical Center, Yokohama, Japan.; Clinical Laboratory, Kanagawa Children's Medical Center, Yokohama, Japan.
Goto H; Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.
Shinkai M; Pediatric Surgery, Kanagawa Children's Medical Center, Yokohama, Japan.
Kitagawa N; Pediatric Surgery, Kanagawa Children's Medical Center, Yokohama, Japan.
Toyoda Y; Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.
Nishi T; Pediatric Surgery, Kanagawa Children's Medical Center, Yokohama, Japan.
Kigasawa H; Hematology/Oncology, Kanagawa Children's Medical Center, Yokohama, Japan.
Tanaka M; Divisions of Pathology, Kanagawa Children's Medical Center, Yokohama, Japan.
Kurosawa K; Medical Genetics, Kanagawa Children's Medical Center, Yokohama, Japan.
Ito Y; Department of Pathology, Tsurumi University School of Dental Medicine, Yokohama, Japan.
Haruta M; Research Institute for Clinical Oncology, Saitama Cancer Center, Saitama, Japan.
Kamijo T; Research Institute for Clinical Oncology, Saitama Cancer Center, Saitama, Japan.
Yoshimi A; Division of Pediatric Hematology and Oncology, Institute of Pediatric Medicine and Cancer Research, Ibaraki Children's Hospital, Futaba-dai 3-3-1, Mito, Ibaraki, Japan.
Tsuchida M; Division of Pediatric Hematology and Oncology, Institute of Pediatric Medicine and Cancer Research, Ibaraki Children's Hospital, Futaba-dai 3-3-1, Mito, Ibaraki, Japan.
Nagahara N; Isotope Research Center, Nippon Medical School, Tokyo, Japan.
Tanaka Y; Divisions of Pathology, Kanagawa Children's Medical Center, Yokohama, Japan.
Pokaż więcej
Źródło:
Human cell [Hum Cell] 2024 Sep; Vol. 37 (5), pp. 1602-1609. Date of Electronic Publication: 2024 Jul 30.
Typ publikacji:
Journal Article; Case Reports
MeSH Terms:
Neuroblastoma*/genetics
Neuroblastoma*/pathology
Proto-Oncogene Proteins c-mdm2*/genetics
Proto-Oncogene Proteins c-mdm2*/metabolism
N-Myc Proto-Oncogene Protein*/genetics
Gene Amplification*/genetics
Humans ; Female ; Child ; Cell Line, Tumor ; Neoplasm Recurrence, Local/genetics ; Neoplasm Recurrence, Local/pathology ; Liver Neoplasms/genetics ; Liver Neoplasms/pathology ; Telomere/genetics ; Cyclin-Dependent Kinase 4/genetics ; Cyclin-Dependent Kinase 4/metabolism ; Telomere Homeostasis/genetics
Czasopismo naukowe
Tytuł:
Molecular profiling of core immune-escape genes highlights TNFAIP3 as an immune-related prognostic biomarker in neuroblastoma.
Autorzy:
Yang L; Department of Pediatric Surgical Oncology Children's Hospitial of Chongqinng Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatric Metabolism and Inflammatory Diseases, Children's Hospital of Chongqing Medical University, Chongqing, China.
Huang K; Department of Pediatric Surgical Oncology Children's Hospitial of Chongqinng Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatric Metabolism and Inflammatory Diseases, Children's Hospital of Chongqing Medical University, Chongqing, China.
Cao L; Department of Pediatric Surgical Oncology Children's Hospitial of Chongqinng Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatric Metabolism and Inflammatory Diseases, Children's Hospital of Chongqing Medical University, Chongqing, China.
Ma Y; Department of Pediatric Surgical Oncology Children's Hospitial of Chongqinng Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatric Metabolism and Inflammatory Diseases, Children's Hospital of Chongqing Medical University, Chongqing, China.
Li S; Department of Pediatric Surgical Oncology Children's Hospitial of Chongqinng Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatric Metabolism and Inflammatory Diseases, Children's Hospital of Chongqing Medical University, Chongqing, China.
Zhou J; Department of Pediatric Surgical Oncology Children's Hospitial of Chongqinng Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatric Metabolism and Inflammatory Diseases, Children's Hospital of Chongqing Medical University, Chongqing, China.
Zhao Z; Department of Pediatric Surgical Oncology Children's Hospitial of Chongqinng Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatric Metabolism and Inflammatory Diseases, Children's Hospital of Chongqing Medical University, Chongqing, China.
Wang S; Department of Pediatric Surgical Oncology Children's Hospitial of Chongqinng Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatric Metabolism and Inflammatory Diseases, Children's Hospital of Chongqing Medical University, Chongqing, China. .
Pokaż więcej
Źródło:
Inflammation research : official journal of the European Histamine Research Society ... [et al.] [Inflamm Res] 2024 Sep; Vol. 73 (9), pp. 1529-1545. Date of Electronic Publication: 2024 Jul 19.
Typ publikacji:
Journal Article
MeSH Terms:
Neuroblastoma*/genetics
Neuroblastoma*/immunology
Tumor Necrosis Factor alpha-Induced Protein 3*/genetics
Biomarkers, Tumor*/genetics
Humans ; Prognosis ; Gene Expression Profiling ; Transcriptome ; Tumor-Associated Macrophages/immunology ; Tumor Escape/genetics ; Gene Expression Regulation, Neoplastic
Czasopismo naukowe
Tytuł:
Response-adapted consolidation therapy strategy for patients with metastatic high-risk neuroblastoma: Results of the SMC NB-2014 study.
Autorzy:
Seo ES; Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.; Department of Digital Health, SAIHST, Sungkyunkwan University, Seoul, Republic of Korea.
Lee JW; Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Cho HW; Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Ju HY; Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Cho YS; Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Lee S; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Moon SH; Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Yoo KH; Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Lim DH; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Sung KW; Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Pokaż więcej
Źródło:
Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Sep; Vol. 71 (9), pp. e31173. Date of Electronic Publication: 2024 Jul 04.
Typ publikacji:
Journal Article; Clinical Trial
MeSH Terms:
Neuroblastoma*/therapy
Neuroblastoma*/mortality
Neuroblastoma*/pathology
Neuroblastoma*/drug therapy
Consolidation Chemotherapy*
3-Iodobenzylguanidine*/therapeutic use
Humans ; Female ; Male ; Child, Preschool ; Infant ; Child ; Prospective Studies ; Survival Rate ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Adolescent ; Follow-Up Studies ; Transplantation, Autologous ; Prognosis ; Hematopoietic Stem Cell Transplantation ; Radiopharmaceuticals
Czasopismo naukowe
Tytuł:
Higher tumor mutational burden is associated with inferior outcomes among pediatric patients with neuroblastoma.
Autorzy:
Chang YH; Institute of Molecular and Genomic Medicine, National Health Research Institute, Miaoli, Taiwan.
Yu CH; Institute of Statistical Science Academia Sinica, Taipei, Taiwan.; Departments of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University, Taipei, Taiwan.
Lu MY; Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan.; Department of Pediatrics, College of Medicine, National Taiwan University, Taipei, Taiwan.
Jou ST; Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan.; Department of Pediatrics, College of Medicine, National Taiwan University, Taipei, Taiwan.
Lin CY; Institute of Statistical Science Academia Sinica, Taipei, Taiwan.
Lin KH; Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan.
Chang HH; Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan.; Department of Pediatrics, College of Medicine, National Taiwan University, Taipei, Taiwan.
Ni YL; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Chou SW; Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan.
Ko KY; Department of Nuclear Medicine, National Taiwan University Cancer Center, Taipei, Taiwan.; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
Lin DT; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Hsu WM; Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan.; Department of Surgery, College of Medicine, National Taiwan University, Taipei, Taiwan.
Chen HY; Institute of Statistical Science Academia Sinica, Taipei, Taiwan.
Yang YL; Department of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan.; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Department of Laboratory Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.; Department of Laboratory Medicine and Medical Service, National Taiwan University Cancer Center, Taipei, Taiwan.
Pokaż więcej
Źródło:
Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Sep; Vol. 71 (9), pp. e31176. Date of Electronic Publication: 2024 Jul 05.
Typ publikacji:
Journal Article
MeSH Terms:
Neuroblastoma*/genetics
Neuroblastoma*/mortality
Neuroblastoma*/pathology
Mutation*
Humans ; Male ; Female ; Child, Preschool ; Infant ; Child ; Prognosis ; Biomarkers, Tumor/genetics ; Survival Rate ; Follow-Up Studies ; DNA Copy Number Variations ; Tumor Burden ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Adolescent
Czasopismo naukowe
Tytuł:
Atypical hemolytic uremic syndrome during induction chemotherapy in neuroblastoma, a rare phenomenon or common congenital predisposition?
Autorzy:
Davitt M; Lisa Dean Mosely Foundation Institute for Cancer and Blood Disorders, Nemours Children's Hospital, Wilmington, Delaware, USA.
Offenbacher R; Division of Pediatric Hematology, Oncology, and Cellular Therapy, Children's Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, New York, USA.
Lee MA; Division of Pediatric Hematology, Oncology, and Cellular Therapy, Children's Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, New York, USA.
Loeb DM; Division of Pediatric Hematology, Oncology, and Cellular Therapy, Children's Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, New York, USA.
Manwani D; Division of Pediatric Hematology, Oncology, and Cellular Therapy, Children's Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, New York, USA.
Mitchell W; Division of Pediatric Hematology, Oncology, and Cellular Therapy, Children's Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, New York, USA.
Weiser DA; Division of Pediatric Hematology, Oncology, and Cellular Therapy, Children's Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, New York, USA.
Pokaż więcej
Źródło:
Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Sep; Vol. 71 (9), pp. e31175. Date of Electronic Publication: 2024 Jul 03.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Neuroblastoma*/drug therapy
Neuroblastoma*/pathology
Neuroblastoma*/genetics
Atypical Hemolytic Uremic Syndrome*/drug therapy
Atypical Hemolytic Uremic Syndrome*/genetics
Atypical Hemolytic Uremic Syndrome*/pathology
Induction Chemotherapy*/adverse effects
Humans ; Male ; Infant ; Complement Factor H/genetics ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Germ-Line Mutation
Czasopismo naukowe
Tytuł:
Overexpression of H2AFX gene in neuroblastoma is associated with worse prognosis.
Autorzy:
Ognibene M; UOC Genetica Medica, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Parodi S; Epidemiologia e Biostatistica, Direzione Scientifica, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Amoroso L; UOC Oncologia Pediatrica, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Zara F; UOC Genetica Medica, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Pezzolo A; IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Pokaż więcej
Źródło:
Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Sep; Vol. 71 (9), pp. e31146. Date of Electronic Publication: 2024 Jun 27.
Typ publikacji:
Journal Article
MeSH Terms:
Neuroblastoma*/genetics
Neuroblastoma*/mortality
Neuroblastoma*/pathology
Neuroblastoma*/metabolism
Histones*/genetics
Histones*/metabolism
Biomarkers, Tumor*/genetics
Biomarkers, Tumor*/metabolism
Humans ; Prognosis ; Male ; Female ; Infant ; Gene Expression Regulation, Neoplastic ; Child, Preschool ; Survival Rate ; Child
Czasopismo naukowe
Tytuł:
Both Enantiomers of 2-Hydroxyglutarate Modulate the Metabolism of Cultured Human Neuroblastoma Cells.
Autorzy:
Gondáš E; Department of Medical Biochemistry, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Malá hora 4D, 036 01, Martin, Slovakia.; Department of Pharmacology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Bratislava, Slovakia.
Baranovičová E; Biomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Bratislava, Slovakia.
Bystrický P; Department of Pharmaceutical Analysis and Nuclear Pharmacy, Faculty of Pharmacy, Comenius University in Bratislava, Bratislava, Slovakia.
Šofranko J; Department of Medical Biochemistry, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Malá hora 4D, 036 01, Martin, Slovakia.
Evinová A; Biomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Bratislava, Slovakia.
Dohál M; Biomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Bratislava, Slovakia.
Hatoková Z; Biomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Bratislava, Slovakia.
Murín R; Department of Medical Biochemistry, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Malá hora 4D, 036 01, Martin, Slovakia. .; Department of Medical Biochemistry, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Malá hora 4D, 036 01, Martin, Slovakia. .
Pokaż więcej
Źródło:
Neurochemical research [Neurochem Res] 2024 Sep; Vol. 49 (9), pp. 2480-2490. Date of Electronic Publication: 2024 Jun 12.
Typ publikacji:
Journal Article
MeSH Terms:
Glutarates*/chemistry
Glutarates*/metabolism
Neuroblastoma*/metabolism
Neuroblastoma*/pathology
Cell Line, Tumor ; Cell Survival ; Hydroxybutyrate Dehydrogenase/metabolism ; Magnetic Resonance Spectroscopy ; Mitochondria/metabolism ; Stereoisomerism ; Humans
Czasopismo naukowe
Tytuł:
Joint single-cell genetic and transcriptomic analysis reveal pre-malignant SCP-like subclones in human neuroblastoma.
Autorzy:
Olsen TK; Department of Women's and Children's Health, Childhood Cancer Research Unit, Karolinska Institutet, Stockholm, 171 77, Sweden.; Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, 752 36, Sweden.
Otte J; Department of Women's and Children's Health, Childhood Cancer Research Unit, Karolinska Institutet, Stockholm, 171 77, Sweden.
Mei S; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, 02115, USA.
Embaie BT; Department of Women's and Children's Health, Childhood Cancer Research Unit, Karolinska Institutet, Stockholm, 171 77, Sweden.
Kameneva P; St. Anna Children's Cancer Research Institute (CCRI), Vienna, Austria.
Cheng H; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, 171 77, Sweden.
Gao T; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, 02115, USA.
Zachariadis V; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, 171 77, Sweden.
Tsea I; Department of Women's and Children's Health, Childhood Cancer Research Unit, Karolinska Institutet, Stockholm, 171 77, Sweden.
Björklund Å; National Bioinformatics Infrastructure Sweden, SciLifeLab, Uppsala University, Uppsala, 752 36, Sweden.
Kryukov E; Department of Ophthalmology, Schepens Eye Research Institute of Massachusetts, Eye and Ear, Boston, MA, 02115, USA.; Department of Ophthalmology, Harvard Medical School, Boston, MA, 02115, USA.
Hou Z; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, 02115, USA.
Johansson A; National Bioinformatics Infrastructure Sweden, SciLifeLab, Uppsala University, Uppsala, 752 36, Sweden.
Sundström E; Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Karolinska Institutet, Stockholm, 171 77, Sweden.
Martinsson T; Department of Laboratory Medicine, The Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, 413 45, Sweden.
Fransson S; Department of Laboratory Medicine, The Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, 413 45, Sweden.
Stenman J; Department of Women's and Children's Health, Childhood Cancer Research Unit, Karolinska Institutet, Stockholm, 171 77, Sweden.
Fard SS; Department of Women's and Children's Health, Childhood Cancer Research Unit, Karolinska Institutet, Stockholm, 171 77, Sweden.
Johnsen JI; Department of Women's and Children's Health, Childhood Cancer Research Unit, Karolinska Institutet, Stockholm, 171 77, Sweden.
Kogner P; Department of Women's and Children's Health, Childhood Cancer Research Unit, Karolinska Institutet, Stockholm, 171 77, Sweden.
Adameyko I; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, 171 77, Sweden.; Department of Neuroimmunology, Center for Brain Research, Medical University Vienna, Vienna, 1090, Austria.
Enge M; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, 171 77, Sweden. .
Kharchenko PV; Department of Biomedical Informatics, Harvard Medical School, Boston, MA, 02115, USA. .; San Diego Institute of Science, Altos Labs, San Diego, CA, 94022, USA. .
Baryawno N; Department of Women's and Children's Health, Childhood Cancer Research Unit, Karolinska Institutet, Stockholm, 171 77, Sweden. .
Pokaż więcej
Źródło:
Molecular cancer [Mol Cancer] 2024 Aug 31; Vol. 23 (1), pp. 180. Date of Electronic Publication: 2024 Aug 31.
Typ publikacji:
Journal Article; Letter
MeSH Terms:
Neuroblastoma*/genetics
Neuroblastoma*/pathology
Neuroblastoma*/metabolism
Single-Cell Analysis*
Schwann Cells*/metabolism
Schwann Cells*/pathology
Gene Expression Profiling*
Humans ; Transcriptome ; Gene Expression Regulation, Neoplastic ; In Situ Hybridization, Fluorescence
Czasopismo naukowe
Tytuł:
Altered methylation of imprinted genes in neuroblastoma: implications for prognostic refinement.
Autorzy:
Suman M; Sahlgrenska Center for Cancer Research, Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Medicinaregatan 1F, 405 30, Gothenburg, Sweden.
Löfgren M; Sahlgrenska Center for Cancer Research, Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Medicinaregatan 1F, 405 30, Gothenburg, Sweden.
Fransson S; Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Yousuf JI; Sahlgrenska Center for Cancer Research, Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Medicinaregatan 1F, 405 30, Gothenburg, Sweden.
Svensson J; Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Djos A; Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Martinsson T; Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Kogner P; Childhood Cancer Research Unit, Women's, and Children's Health, Karolinska Institutet, Stockholm, Sweden.
Kling T; Sahlgrenska Center for Cancer Research, Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Medicinaregatan 1F, 405 30, Gothenburg, Sweden.
Carén H; Sahlgrenska Center for Cancer Research, Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Medicinaregatan 1F, 405 30, Gothenburg, Sweden. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2024 Aug 31; Vol. 22 (1), pp. 808. Date of Electronic Publication: 2024 Aug 31.
Typ publikacji:
Journal Article
MeSH Terms:
Neuroblastoma*/genetics
Neuroblastoma*/pathology
DNA Methylation*/genetics
Genomic Imprinting*/genetics
Humans ; Prognosis ; Male ; Female ; DNA Copy Number Variations/genetics ; Alleles ; Child, Preschool ; Infant ; Gene Expression Regulation, Neoplastic
Czasopismo naukowe
Tytuł:
Joint metabolomics and transcriptomics analysis systematically reveal the impact of MYCN in neuroblastoma.
Autorzy:
Du B; Health Commission of Henan Province Key Laboratory for Precision Diagnosis and Treatment of Pediatric Tumor, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018, China.
Zhang Y; The First Affiliated Hospital, College of Clinical Medicine of Henan University of Science and Technology, Henan Key Laboratory of Rare Diseases, Endocrinology and Metabolism Center, Luoyang, 471003, China.
Zhang P; Health Commission of Henan Province Key Laboratory for Precision Diagnosis and Treatment of Pediatric Tumor, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018, China.
Zhang M; Health Commission of Henan Province Key Laboratory for Precision Diagnosis and Treatment of Pediatric Tumor, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018, China.
Yu Z; Health Commission of Henan Province Key Laboratory for Precision Diagnosis and Treatment of Pediatric Tumor, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018, China.
Li L; Health Commission of Henan Province Key Laboratory for Precision Diagnosis and Treatment of Pediatric Tumor, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018, China.
Hou L; Henan International Joint Laboratory for Prevention and Treatment of Pediatric Disease, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018, China.
Wang Q; Henan Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018, China. .
Zhang X; Health Commission of Henan Province Key Laboratory for Precision Diagnosis and Treatment of Pediatric Tumor, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018, China. .
Zhang W; Health Commission of Henan Province Key Laboratory for Precision Diagnosis and Treatment of Pediatric Tumor, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018, China. .; Henan International Joint Laboratory for Prevention and Treatment of Pediatric Disease, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018, China. .; Henan Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Aug 30; Vol. 14 (1), pp. 20155. Date of Electronic Publication: 2024 Aug 30.
Typ publikacji:
Journal Article
MeSH Terms:
Neuroblastoma*/genetics
Neuroblastoma*/metabolism
Neuroblastoma*/pathology
N-Myc Proto-Oncogene Protein*/genetics
N-Myc Proto-Oncogene Protein*/metabolism
Metabolomics*/methods
Gene Expression Profiling*
Humans ; Gene Expression Regulation, Neoplastic ; Transcriptome ; Male ; Female ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Child, Preschool ; Metabolic Networks and Pathways/genetics ; Infant
Czasopismo naukowe
Tytuł:
Comprehensive analysis identifies ubiquitin ligase FBXO42 as a tumor-promoting factor in neuroblastoma.
Autorzy:
Zhou J; Department of Pediatric Surgical Oncology, Children's Hospital of Chongqing Medical University; and the National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing, 400014, People's Republic of China.
Li Q; Laboratory Animal Center, Chongqing Medical University, Chongqing, 400016, People's Republic of China.
Deng X; Department of Pediatric Surgical Oncology, Children's Hospital of Chongqing Medical University; and the National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing, 400014, People's Republic of China.
Peng L; Department of Pediatric Surgical Oncology, Children's Hospital of Chongqing Medical University; and the National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing, 400014, People's Republic of China.
Sun J; Department of Pediatric Surgical Oncology, Children's Hospital of Chongqing Medical University; and the National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing, 400014, People's Republic of China.
Zhang Y; Department of Pediatric Surgical Oncology, Children's Hospital of Chongqing Medical University; and the National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing, 400014, People's Republic of China.
Du Y; Department of Pediatric Surgical Oncology, Children's Hospital of Chongqing Medical University; and the National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing, 400014, People's Republic of China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Aug 12; Vol. 14 (1), pp. 18697. Date of Electronic Publication: 2024 Aug 12.
Typ publikacji:
Journal Article
MeSH Terms:
Neuroblastoma*/metabolism
Neuroblastoma*/genetics
Neuroblastoma*/pathology
Cell Proliferation*
Humans ; Prognosis ; Male ; Ubiquitination ; Cell Line, Tumor ; Female ; Proteomics/methods ; Gene Expression Regulation, Neoplastic ; Tumor Suppressor Protein p53/metabolism ; Tumor Suppressor Protein p53/genetics ; Ubiquitin-Protein Ligases/metabolism ; Ubiquitin-Protein Ligases/genetics ; Biomarkers, Tumor/metabolism ; Biomarkers, Tumor/genetics ; F-Box Proteins/metabolism ; F-Box Proteins/genetics ; Child, Preschool ; Infant ; Child
Czasopismo naukowe
Tytuł:
Prenyl Pterocarpans from Algerian Bituminaria bituminosa and Their Effects on Neuroblastoma.
Autorzy:
Benhabrou H; Université de Batna 1, Faculté des Sciences de la Matière, Département de Chimie, Laboratoire de Chimie et Chimie de l'Environnement (LCCE), Batna 05000, Algeria.
Bitam F; Université de Batna 2, Faculté de Médecine, Département de Pharmacie, Batna 05000, Algeria.
Cristino L; Consiglio Nazionale delle Ricerche, Istituto di Chimica Biomolecolare, Via Campi Flegrei 34, 80078 Pozzuoli, Italy.
Nicois A; Consiglio Nazionale delle Ricerche, Istituto di Chimica Biomolecolare, Via Campi Flegrei 34, 80078 Pozzuoli, Italy.; Università di Urbino 'Carlo Bo', Dipartimento di Scienze Biomolecolari, Via Santa Chiara, 27, 61029 Urbino, Italy.
Carbone M; Consiglio Nazionale delle Ricerche, Istituto di Chimica Biomolecolare, Via Campi Flegrei 34, 80078 Pozzuoli, Italy.
Ammar D; Université de Batna 1, Faculté des Sciences de la Matière, Département de Chimie, Laboratoire de Chimie et Chimie de l'Environnement (LCCE), Batna 05000, Algeria.
Gavagnin M; Consiglio Nazionale delle Ricerche, Istituto di Chimica Biomolecolare, Via Campi Flegrei 34, 80078 Pozzuoli, Italy.
Ciavatta ML; Consiglio Nazionale delle Ricerche, Istituto di Chimica Biomolecolare, Via Campi Flegrei 34, 80078 Pozzuoli, Italy.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2024 Aug 02; Vol. 29 (15). Date of Electronic Publication: 2024 Aug 02.
Typ publikacji:
Journal Article
MeSH Terms:
Neuroblastoma*/pathology
Neuroblastoma*/drug therapy
Pterocarpans*/chemistry
Pterocarpans*/pharmacology
Pterocarpans*/isolation & purification
Antineoplastic Agents, Phytogenic*/pharmacology
Antineoplastic Agents, Phytogenic*/chemistry
Antineoplastic Agents, Phytogenic*/isolation & purification
Humans ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Molecular Structure ; Plant Extracts/chemistry ; Plant Extracts/pharmacology ; Apoptosis/drug effects
Czasopismo naukowe
Tytuł:
Single-cell RNA-seq reveals the transcriptional program underlying tumor progression and metastasis in neuroblastoma.
Autorzy:
Nian Z; Department of Immunology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, 300070, China.
Wang D; Department of Immunology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, 300070, China.
Wang H; Department of Immunology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, 300070, China.
Liu W; Department of Immunology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, 300070, China.
Ma Z; Zhejiang Key Laboratory of Medical Epigenetics, Department of Cell Biology, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, 311121, China.
Yan J; Department of Pediatric Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, China.
Cao Y; Department of Pediatric Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, China.
Li J; Department of Pediatric Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, China.
Zhao Q; Department of Pediatric Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, China. .
Liu Z; Department of Immunology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, 300070, China. .; Zhejiang Key Laboratory of Medical Epigenetics, Department of Cell Biology, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, 311121, China. .; Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, 211166, China. .
Pokaż więcej
Źródło:
Frontiers of medicine [Front Med] 2024 Aug; Vol. 18 (4), pp. 690-707. Date of Electronic Publication: 2024 Jul 17.
Typ publikacji:
Journal Article
MeSH Terms:
Neuroblastoma*/genetics
Neuroblastoma*/pathology
Disease Progression*
Epithelial-Mesenchymal Transition*/genetics
Single-Cell Analysis*
RNA-Seq*
Gene Expression Regulation, Neoplastic*
Humans ; Neoplasm Metastasis/genetics ; Transcriptome ; Gene Expression Profiling ; Single-Cell Gene Expression Analysis
Czasopismo naukowe
Tytuł:
Effective suppression of tumor growth and hepatic metastasis of neuroblastoma by NKT-stimulatory phenyl glycolipid.
Autorzy:
Wu TN; Agricultural Biotechnology Research Center, Academia Sinica, Taipei 115, Taiwan; Institute of Biotechnology, National Taiwan University, Taipei 115, Taiwan. Electronic address: .
Hung JT; Institute of Stem Cell and Translational Cancer Research, Chang Gung Memorial Hospital at Linkou, Chang Gung University, Taoyuan, Taiwan. Electronic address: .
Hung TH; Institute of Stem Cell and Translational Cancer Research, Chang Gung Memorial Hospital at Linkou, Chang Gung University, Taoyuan, Taiwan.
Wang YH; Institute of Stem Cell and Translational Cancer Research, Chang Gung Memorial Hospital at Linkou, Chang Gung University, Taoyuan, Taiwan.
Wu JC; Institute of Stem Cell and Translational Cancer Research, Chang Gung Memorial Hospital at Linkou, Chang Gung University, Taoyuan, Taiwan.
Yu AL; Institute of Stem Cell and Translational Cancer Research, Chang Gung Memorial Hospital at Linkou, Chang Gung University, Taoyuan, Taiwan; Department of Pediatrics, University of California in San Diego, La Jolla, CA, USA.
Pokaż więcej
Źródło:
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2024 Aug; Vol. 177, pp. 117040. Date of Electronic Publication: 2024 Jul 02.
Typ publikacji:
Journal Article
MeSH Terms:
Neuroblastoma*/pathology
Neuroblastoma*/drug therapy
Neuroblastoma*/immunology
Natural Killer T-Cells*/drug effects
Natural Killer T-Cells*/immunology
Natural Killer T-Cells*/metabolism
Liver Neoplasms*/drug therapy
Liver Neoplasms*/pathology
Liver Neoplasms*/immunology
Liver Neoplasms*/secondary
Glycolipids*/pharmacology
Animals ; Cell Line, Tumor ; Mice ; Humans ; Female ; Cytokines/metabolism ; Myeloid-Derived Suppressor Cells/drug effects ; Myeloid-Derived Suppressor Cells/immunology ; Myeloid-Derived Suppressor Cells/metabolism ; Antineoplastic Agents/pharmacology ; Galactosylceramides/pharmacology
Czasopismo naukowe
Tytuł:
Anlotinib induces neuronal-like differentiation of neuroblastoma by downregulating CRMP5.
Autorzy:
Hu J; Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Yang W; Department of Infectious Diseases, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Wang K; Department of Traditional Chinese Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Xu H; Department of General Surgery, The Affiliated Children's Hospital of Nanchang Medical College, Nangchang, China.; Department of General Surgery, Jiangxi Provincial Children's Hospital, Nanchang, Jiangxi, China.
Chen T; Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Li C; Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Xiong T; Department of General Surgery, Jiangxi Provincial Children's Hospital, Nanchang, Jiangxi, China.
Xu H; Department of General Surgery, Jiangxi Provincial Children's Hospital, Nanchang, Jiangxi, China.
Luo M; Department of General Surgery, Jiangxi Provincial Children's Hospital, Nanchang, Jiangxi, China.
Zhang S; Department of General Surgery, The Affiliated Children's Hospital of Nanchang Medical College, Nangchang, China.; Department of General Surgery, Jiangxi Provincial Children's Hospital, Nanchang, Jiangxi, China.
Yan J; Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Pokaż więcej
Źródło:
Molecular carcinogenesis [Mol Carcinog] 2024 Aug; Vol. 63 (8), pp. 1559-1571. Date of Electronic Publication: 2024 May 23.
Typ publikacji:
Journal Article
MeSH Terms:
Neuroblastoma*/drug therapy
Neuroblastoma*/pathology
Neuroblastoma*/metabolism
Neuroblastoma*/genetics
Quinolines*/pharmacology
Cell Differentiation*/drug effects
Xenograft Model Antitumor Assays*
Indoles*/pharmacology
Nerve Tissue Proteins*/metabolism
Nerve Tissue Proteins*/genetics
Cell Proliferation*/drug effects
Humans ; Animals ; Mice ; Cell Line, Tumor ; Gene Expression Regulation, Neoplastic/drug effects ; Down-Regulation/drug effects ; Neurons/drug effects ; Neurons/metabolism ; Neurons/pathology ; Mice, Nude ; Hydrolases/genetics ; Hydrolases/metabolism ; Antineoplastic Agents/pharmacology ; Microtubule-Associated Proteins
Czasopismo naukowe
Tytuł:
A non-inferiority study of MRI versus CT for staging and image-defined risk factor assessment in the preoperative work-up of abdominopelvic neuroblastoma.
Autorzy:
Delval A; Department of Radiology, Amiens University Hospital, F-80054 Amiens, France. Electronic address: .
Touitou T; Department of Radiology, Amiens University Hospital, F-80054 Amiens, France. Electronic address: .
Gondry-Jouet C; Department of Radiology, Amiens University Hospital, F-80054 Amiens, France. Electronic address: .
Khanfar C; Department of Paediatric Oncology, Amiens University Hospital, F-80054 Amiens, France. Electronic address: .
Haraux E; Department of Paediatric Surgery, Amiens University Hospital, F-80054 Amiens, France. Electronic address: .
Pokaż więcej
Źródło:
European journal of radiology [Eur J Radiol] 2024 Aug; Vol. 177, pp. 111580. Date of Electronic Publication: 2024 Jun 17.
Typ publikacji:
Journal Article; Comparative Study
MeSH Terms:
Neuroblastoma*/diagnostic imaging
Neuroblastoma*/surgery
Neuroblastoma*/pathology
Magnetic Resonance Imaging*/methods
Contrast Media*
Tomography, X-Ray Computed*/methods
Abdominal Neoplasms*/diagnostic imaging
Abdominal Neoplasms*/surgery
Preoperative Care*/methods
Neoplasm Staging*
Humans ; Female ; Male ; Child, Preschool ; Infant ; Risk Factors ; Child ; Risk Assessment ; Pelvic Neoplasms/diagnostic imaging ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Adolescent- and adult-onset neuroblastic tumor: A retrospective multicenter observational study of patients diagnosed in France between 2000 and 2020.
Autorzy:
Magnier O; Cancer and Blood Diseases Department, Medical Oncology, Grenoble Alpes University Hospital, Grenoble, France.
Schiff I; Pediatric Oncology and Hematology Department, Grenoble Alpes University, Grenoble, France.
Cristante J; Endocrinology Department, Grenoble Alpes University, Grenoble, France.
Chabre O; Endocrinology Department, Grenoble Alpes University, Grenoble, France.
Veloso M; Public Health and Biostatistics, Grenoble Alpes University Hospital, Grenoble, France.
Bosson JL; Public Health and Biostatistics, Grenoble Alpes University Hospital, Grenoble, France.
Defachelles AS; Pediatric and AYA Oncology Department, Oscar Lambret Center, Lille, France.
Cordero C; Pediatric Oncology Department, Curie Institute, Paris, France.
Cao CD; Department of Endocrinology, Diabetology, and Metabolism, Lille University Hospital, Lille, France.
Thebaud E; Pediatric Oncology Department, Nantes University Hospital, Nantes, France.
Drui D; Endocrinology Department, Nantes University Hospital, Nantes, France.
Berlanga P; Pediatric and AYA Oncology Department, Gustave Roussy Institute, Paris, France.
Dumont B; Pediatric Oncology Department, IHOPe, Lyon, France.
Chastagner P; Pediatric Oncology and Hematology Department, Nancy University Hospital, Nancy, France.
Tandonnet J; Pediatric Oncology Department, Bordeaux University Hospital, Bordeaux, France.
Gambart M; Pediatric Oncology and Hematology Department, Toulouse University Hospital, Toulouse, France.
Jannier S; Pediatric Oncology Department, Strasbourg University Hospital, Strasbourg, France.
Pluchart C; Pediatric Oncology and Hematology Department, Reims University Hospital, Reims, France.
Andry L; Pediatric Oncology Department, Amiens University Hospital, Amiens, France.
Laithier V; Pediatric Oncology Department, Besançon University Hospital, Besançon, France.
Klein S; Pediatric Oncology Department, Besançon University Hospital, Besançon, France.
Carausu L; Pediatric Oncology and Hematology Department, Brest University Hospital, Brest, France.
Akbaraly T; Pediatric Oncology Department, Montpellier University Hospital, Montpellier, France.
Probert J; Pediatric Oncology and Hematology Department, Rennes University Hospital, Rennes, France.
Habert-Dantigny R; Cancer and Blood Diseases Department, Medical Oncology, Palliative Care Unit, Grenoble Alpes University, Grenoble, France.
Plantaz D; Pediatric Oncology and Hematology Department, Grenoble Alpes University, Grenoble, France.
Pokaż więcej
Źródło:
Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Aug; Vol. 71 (8), pp. e31074. Date of Electronic Publication: 2024 May 22.
Typ publikacji:
Journal Article; Multicenter Study; Observational Study
MeSH Terms:
Neuroblastoma*/therapy
Neuroblastoma*/epidemiology
Neuroblastoma*/pathology
Neuroblastoma*/mortality
Neuroblastoma*/diagnosis
Humans ; Retrospective Studies ; Adolescent ; Male ; Female ; Adult ; Young Adult ; France/epidemiology ; Survival Rate ; Middle Aged ; Adrenal Gland Neoplasms/therapy ; Adrenal Gland Neoplasms/epidemiology ; Adrenal Gland Neoplasms/pathology ; Adrenal Gland Neoplasms/mortality ; Adrenal Gland Neoplasms/diagnosis ; Pheochromocytoma/therapy ; Pheochromocytoma/epidemiology ; Pheochromocytoma/pathology ; Pheochromocytoma/mortality ; Follow-Up Studies ; Combined Modality Therapy ; Prognosis ; Age of Onset ; Ganglioneuroblastoma/therapy ; Ganglioneuroblastoma/pathology ; Ganglioneuroblastoma/epidemiology ; Ganglioneuroblastoma/mortality ; Aged
Czasopismo naukowe
Tytuł:
Congenital metastatic neuroblastoma with placental involvement as a rare cause of non-immune fetal hydrops.
Autorzy:
Campillo-Ajenjo M; Obstetrics and Gynecology Department, La Paz University Hospital, Madrid, Spain.
Pena-Burgos EM; Pathology Department, La Paz University Hospital, Madrid, Spain.
Herrero Ruiz B; Obstetrics and Gynecology Department, La Paz University Hospital, Madrid, Spain.
Escuer Albero G; Pathology Department, La Paz University Hospital, Madrid, Spain.
Rubio Aparicio P; Pediatric Oncology Department, La Paz University Hospital, Madrid, Spain.
Parrón Pajares M; Radiology Department, La Paz University Hospital, Madrid, Spain.
Bret Zurita M; Radiology Department, La Paz University Hospital, Madrid, Spain.
Regojo-Zapata RM; Pathology Department, La Paz University Hospital, Madrid, Spain.
Bartha Rasero JL; Obstetrics and Gynecology Department, La Paz University Hospital, Madrid, Spain.
Antolín Alvarado E; Obstetrics and Gynecology Department, La Paz University Hospital, Madrid, Spain.
Pokaż więcej
Źródło:
The journal of obstetrics and gynaecology research [J Obstet Gynaecol Res] 2024 Aug; Vol. 50 (8), pp. 1402-1407. Date of Electronic Publication: 2024 May 15.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Hydrops Fetalis*
Neuroblastoma*
Humans ; Female ; Pregnancy ; Adrenal Gland Neoplasms ; Adult ; Pregnancy Complications, Neoplastic/pathology ; Placenta/pathology
Czasopismo naukowe
Tytuł:
Multi-modal 3-Dimensional Visualization of Pediatric Neuroblastoma: Aiding Surgical Planning Beyond Anatomical Information.
Autorzy:
Simons DC; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584, CS, Utrecht, the Netherlands; University of Twente, Technical Medicine, Hallenweg 5, 7522, NH, Enschede, the Netherlands.
Buser MAD; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584, CS, Utrecht, the Netherlands.
Fitski M; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584, CS, Utrecht, the Netherlands.
van de Ven CP; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584, CS, Utrecht, the Netherlands.
Ten Haken B; University of Twente, Magnetic Detection and Imaging, Enschede, the Netherlands.
Wijnen MHWA; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584, CS, Utrecht, the Netherlands.
Tan CO; University of Twente, Electrical Engineering, Mathematics, and Computer Science, Hallenweg 5, 7522, NH, Enschede, the Netherlands.
van der Steeg AFW; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584, CS, Utrecht, the Netherlands. Electronic address: .
Pokaż więcej
Źródło:
Journal of pediatric surgery [J Pediatr Surg] 2024 Aug; Vol. 59 (8), pp. 1575-1581. Date of Electronic Publication: 2024 Feb 24.
Typ publikacji:
Journal Article
MeSH Terms:
Neuroblastoma*/diagnostic imaging
Neuroblastoma*/surgery
Neuroblastoma*/pathology
Imaging, Three-Dimensional*
Humans ; Child ; Child, Preschool ; Female ; Male ; Single Photon Emission Computed Tomography Computed Tomography/methods ; Infant ; Retrospective Studies ; Radiopharmaceuticals ; 3-Iodobenzylguanidine ; Algorithms ; Magnetic Resonance Imaging/methods ; Diffusion Magnetic Resonance Imaging/methods ; Multimodal Imaging/methods
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies